With more patients taking glucagonlike peptide 1 (GLP-1) agonists like Ozempic to control diabetes and obesity, clinicians may need to rethink how to manage them during dental anesthesia or sedation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback